Cholesterol drug could slash liver cancer risk in scarred livers
Prevention
Recruiting now
This study tests whether atorvastatin, a widely used cholesterol medication, can reduce the risk of developing liver cancer in people with advanced liver fibrosis or cirrhosis. About 60 adults at high risk will receive either atorvastatin or a placebo for up to 48 weeks. The main…
Phase: PHASE2 • Sponsor: Raymond Chung • Aim: Prevention
Last updated May 15, 2026 11:55 UTC